// App-Quantinova.ai

: - Underlying clusters of NIA-AA Research Framework stage 2 criteria and their relationship with AD biomarkers in the DELCODE study

Researchers

Presenter

  • Lena Sannemann

Principal Investigators

  • Dix U. Meiberth

  • Ann-Katrin Schild

  • Katharina Bürger

  • Michael T. Heneka

  • Laske Christoph

  • Robert Perneczky

  • Oliver Peters

  • Josef Priller

  • Anja Schneider

  • Annika Spottke

  • Stefan Teipel

  • Jens Wiltfang

  • Steffen Wolfsgruber

  • Michael Wagner

  • Emrah Duzel

  • Frank Jessen

Medical Centers

  • Imperial College, London, UK

  • Department of Neurology, University of Pennsylvania

  • Neurosciences and Signaling Group, Institute of Biomedicine (iBiMED), Department of Medical Sciences, University of Aveiro

  • Otto-von-Guericke University

  • Institute for Cognitive Neurology and Dementia Research (IKND), Otto-von-Guericke University

  • Institute for Stroke and Dementia Research

  • University of Cologne, Faculty of Medicine and University Hospital Cologne

  • University of Edinburgh and UK DRI

  • University Hospital, LMU

  • University of Maryland Medical Center,...

  • University Medical Center Groningen

  • Munich Cluster for Systems Neurology (SyNergy)

  • German Center for Neurodegenerative Diseases (DZNE), Rostock, Germany

  • Technical University of Munich, School of Medicine

  • Hertie Institute for Clinical Brain Research and Department of Psychiatry and Psychotherapy, University of Tübingen

  • German Center for Neurodegenarative Diseases (DZNE)

  • German Center for Neurodegenarative Diseases (DZNE)

  • Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), University of Cologne, Cologne, Germany

  • Department of Psychiatry and Psychotherapy, Charité

  • Rostock University Medical Centre

Locations

  • United Kingdom

  • Germany

  • Portugal

Companies

  • N/A

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

Disease

  • Depression

  • Dementia

  • Anxiety

Biomarkers

  • Cerebrospinal fluid

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A